Marten Visser

1.5k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Marten Visser is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Marten Visser has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Marten Visser's work include Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (11 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Marten Visser is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (11 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Marten Visser collaborates with scholars based in Netherlands, Denmark and United Kingdom. Marten Visser's co-authors include Els M.E. Verdegaal, Sjoerd H. van der Burg, John B.A.G. Haanen, Ton N. Schumacher, Marit M. van Buuren, Hergen Spits, Remko Schotte, Ellen Kapiteijn, Dris El Atmioui and Michael R. Stratton and has published in prestigious journals such as Nature, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Marten Visser

13 papers receiving 1.1k citations

Hit Papers

High-throughput epitope discovery reveals frequent recogn... 2014 2026 2018 2022 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
    2014 527 citations Carsten Linnemann, Marit M. van Buuren et al. Nature Medicine profile →

Peers

Marten Visser
Daisy Philips Netherlands
Wouter Scheper Netherlands
Isaac Kriley United States
Michelle R. Padget United States
Tiffany C. Blair United States
Takashi Inozume Japan
Jan L. Fisher United States
Josephine R. Giles United States
Elixabet Bolaños Spain
Kasia Trebska-McGowan United States
Daisy Philips Netherlands
Marten Visser
Citations per year, relative to Marten Visser Marten Visser (= 1×) peers Daisy Philips

Countries citing papers authored by Marten Visser

Since Specialization
Citations

This map shows the geographic impact of Marten Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marten Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marten Visser more than expected).

Fields of papers citing papers by Marten Visser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marten Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marten Visser. The network helps show where Marten Visser may publish in the future.

Co-authorship network of co-authors of Marten Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Marten Visser. A scholar is included among the top collaborators of Marten Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marten Visser. Marten Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Verdegaal, Els M.E., Saskia J. Santegoets, Marij J.P. Welters, et al.. (2023). Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer. Journal for ImmunoTherapy of Cancer. 11(11). e007697–e007697. 16 indexed citations
2.
Gezgin, Gülçin, Marten Visser, Dina Ruano, et al.. (2022). Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment. SHILAP Revista de lepidopterología. 2(2). 100132–100132. 14 indexed citations
3.
Abbott, Rachel, Tom Hofland, Michael J. Crowther, et al.. (2022). 343 Identification of tumor-reactive T cells targeting melanoma Dark Antigens™ validates this novel class of targets for development of immunotherapies. Regular and Young Investigator Award Abstracts. A361–A361.
4.
5.
6.
Visser, Marten, Nataschja I. Ho, Wim Jiskoot, et al.. (2020). Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines. ChemBioChem. 22(7). 1215–1222. 5 indexed citations
7.
Verdegaal, Els M.E., Monique K. van der Kooij, Marten Visser, et al.. (2020). Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study. Journal for ImmunoTherapy of Cancer. 8(1). e000166–e000166. 19 indexed citations
8.
Bulk, Jitske van den, Els M.E. Verdegaal, Dina Ruano, et al.. (2019). Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4. Genome Medicine. 11(1). 87–87. 47 indexed citations
9.
Melief, Sara M., Valeria Visconti, Marten Visser, et al.. (2017). Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature. Cancer Immunology Research. 5(2). 170–179. 24 indexed citations
10.
Melief, Sara M., Marten Visser, Sjoerd H. van der Burg, & Els M.E. Verdegaal. (2017). IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma. Cancer Immunology Immunotherapy. 66(7). 913–926. 16 indexed citations
11.
Verdegaal, Els M.E., Noel F.C.C. de Miranda, Marten Visser, et al.. (2016). Neoantigen landscape dynamics during human melanoma–T cell interactions. Nature. 536(7614). 91–95. 339 indexed citations
12.
Linnemann, Carsten, Marit M. van Buuren, Laura Bies, et al.. (2016). High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma (vol 21, pg 81, 2015). Pure Amsterdam UMC. 22(10).
13.
Linnemann, Carsten, Marit M. van Buuren, Laura Bies, et al.. (2014). High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nature Medicine. 21(1). 81–85. 527 indexed citations breakdown →
14.
Paus, Roelof A. de, Annelies van Wengen, Iris Schmidt, et al.. (2013). Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β. Cytokine. 61(2). 645–655. 48 indexed citations
15.
Verdegaal, Els M.E., Marten Visser, Tamara H. Ramwadhdoebé, et al.. (2011). Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha. Cancer Immunology Immunotherapy. 60(7). 953–963. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daisy Philips Breakdown of academic impact, for papers by Wouter Scheper Breakdown of academic impact, for papers by Isaac Kriley Breakdown of academic impact, for papers by Michelle R. Padget Breakdown of academic impact, for papers by Tiffany C. Blair Breakdown of academic impact, for papers by Takashi Inozume Breakdown of academic impact, for papers by Jan L. Fisher Breakdown of academic impact, for papers by Josephine R. Giles Breakdown of academic impact, for papers by Elixabet Bolaños Breakdown of academic impact, for papers by Kasia Trebska-McGowan
Rankless by CCL
2026